NORML

JUNE 6, 2019

Steve Sisolak has signed legislation, Senate Bill 430 , expanding the pool of patients eligible for medical cannabis therapy. The measure allows patients diagnosed with anxiety disorders, autism, chronic pain, opioid dependency, and other conditions to obtain a recommendation for medical cannabis.

Chronic Pain 250

Chronic Pain Therapy Legislation Patients 250

United Patients Group

OCTOBER 25, 2024

This condition is known as Cannabis Use Disorder (CUD). Cannabis Use Disorder is a condition where an individual becomes dependent on cannabis, leading to problematic patterns of use. In this blog, we’ll explore what cannabis use disorder is, its causes, symptoms, and the available treatments. What is Cannabis Use Disorder?

Treatment 98

Treatment Therapy Conditions Consumption 98

NORML

MAY 19, 2020

House Bill 819 , which House members passed by a vote of 77 to 15, expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Access 256

Access Therapy Patients Conditions 256

Project CBD

FEBRUARY 1, 2023

For decades, researchers have studied cannabinoids’ ability to treat clinical skin conditions like acne, ulcers, and dermatitis. 3 It’s even possible that cannabinoids taken internally, and not simply via a localized topical, may be able to help — especially if a condition is more widespread. 11,24 4102. 36,1 (2023): 18-23.

Conditions 130

Conditions THC CBD Cannabinoids 130

NORML

JUNE 19, 2020

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

Patients 344

Patients Chronic Pain Treatment Therapy 344

Veriheal

FEBRUARY 27, 2024

The standard treatments for this condition include corticosteroids and other medications, which can be tough on a dog’s liver. Since CBD is safe for long-term use, dogs with chronic conditions like DLE can comfortably use it for extended periods with little risk of adverse effects.

Conditions 110

Conditions Therapy Treatment CBD 110

NORML

JUNE 1, 2020

On Sunday, legislators finalized HB 819 , which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Access 226

Access Therapy Legislation Patients 226

LifeCannMD

JANUARY 31, 2025

Fernando Fandio-Sende has had countless conversations with patients with autoimmune conditions. We’re aware that each person’s medical condition presents unique challenges with can be deeply personal. Dr. Sende offers Medical Marijuana recommendations for patients with one of Floridas qualifying conditions.

Conditions 97

Conditions Research and Development Treatment Patients 97

NORML

FEBRUARY 25, 2020

They concluded : “The addition of dronabinol resulted in reduced opioid consumption, … suggesting a beneficial opioid-sparing effect of dronabinol in acutely painful conditions. An abstract of the study, “Matched pilot study examining cannabis-based dronabinol for acute pain following traumatic injury,” is online here.

Clinical Trials 257

Clinical Trials THC Consumption Therapy 257

Veriheal

MARCH 1, 2022

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. ” . .”

Therapy 98

Therapy Programs Microdosing Medicine 98

NORML

MARCH 14, 2019

Blumenauer said, “For too long, our veterans have been denied access to highly effective medical marijuana treatment for conditions like chronic pain and PTSD. Medical marijuana has shown proven benefits for treating these conditions denying our veterans access to them is shameful.

Access 232

Access Chronic Pain Treatment Conditions 232

NORML

JUNE 10, 2020

According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5 percent in 2016).” ” Public comments “are part of the public record and are subject to public disclosure.

Chronic Pain 256

Chronic Pain Therapy Patients Topical 256

NORML

APRIL 25, 2019

House Bill 1519 significantly expands the pool of patients eligible for medical cannabis therapy to include those diagnosed with autism spectrum disorder, migraine, anorexia, and Tourette Syndrome, among other debilitating conditions.

Law 208

Law Therapy Legislation Programs 208

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

MAY 28, 2021

(CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“ Field Trip “), a leader in the development and delivery of psychedelic therapies, is pleased to announce that it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX). Investor contacts: Elizabeth Barker. 212-896-1203.

Conditions 98

Conditions Research and Development Therapy Events 98

Cannabis Law Report

JUNE 16, 2021

We are excited to explore the potential of emergent psychedelic therapies. Wake is currently developing fungus-derived psilocybin and medicinal mushroom products and is making advancements in the engineering of novel psychedelic biologics, while working on proving out their safety through proprietary genetics-based integration therapies.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

NORML

JUNE 14, 2019

A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction CAPS (Clinician Administered Post-traumatic Scale) symptom scores following cannabis therapy.

Marijuana 276

Marijuana Access Programs Legislation 276

MMJ Recs

DECEMBER 28, 2023

As the medical community delves into the therapeutic potential of cannabis, certain health conditions have emerged as primary candidates for its prescription. THC, the psychoactive component of cannabis, has analgesic properties that can help manage chronic pain conditions, such as neuropathic pain and arthritis.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.

Chronic Pain 212

Chronic Pain Patients Therapy Data 212

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions. A copy of the bill is available here.

Legislation 229

Legislation Access Chronic Pain Marijuana 229

NORML

MARCH 18, 2019

It expands the pool of patients eligible for cannabis therapy to include those diagnosed with post-traumatic stress, severe chronic pain, Crohn’s disease, Lou Gehrig’s disease, sleep apnea, and neuropathy, among other newly specified conditions.

Decriminalization 228

Decriminalization Chronic Pain Marijuana Legislation 228

NORML

NOVEMBER 8, 2019

Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 235

Access Marijuana Treatment Legislation 235

FloridaMarijuana.net

JUNE 12, 2018

The Epilepsy Foundation defines epilepsy as a chronic condition of the brain which causes seizures and affects 65 million people worldwide. It is not fully known the genetic origins of epilepsy or if the condition is hereditary. One in 26 people will develop epilepsy in their lifetime. appeared first on.

Epilepsy 187

Epilepsy Patients Marijuana Research and Development 187

FloridaMarijuana.net

AUGUST 15, 2018

While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions. Get your Florida Medical Marijuana Card.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

NORML

JUNE 13, 2019

Many are having serious difficulty calculating and covering annual expenses for marijuana therapy. Certain conditions require more cannabinoids than others. The biggest reason price is such an issue is because there are no regular health insurance offsets for cannabis products.

Marijuana 278

Marijuana Dispensary Patients Retail 278

NORML

NOVEMBER 1, 2019

.” Separate studies – such as those here , here , and here – consistently report that pain patients often reduce their use of opioids following access to medical cannabis therapy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 175

Access Patients Chronic Pain Law 175

NORML

JANUARY 18, 2019

Senator Anna Wishart (D) has re-introduced legislation, LB 110, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis. Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. AK resident?

Legislation 188

Legislation Decriminalization Access Therapy 188

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. NH resident? CO resident?

Legislation 219

Legislation Decriminalization Hemp Patients 219

Veriheal

OCTOBER 13, 2023

Senator Jeff Irwin, the bill’s sponsor, argued that we must acknowledge the growing research on the potential of psychedelics to help with mental health conditions. Specifically, the Senator emphasized how these substances could help veterans experiencing conditions like PTSD and depression. Ketamine Therapy For All?

Therapy 103

Therapy Legalization Recreational Policy 103

MMJ Recs

MAY 15, 2024

Anxiety is a mental health disorder that stands as one of the most prevalent and debilitating conditions affecting millions of individuals worldwide. Anxiety disorders encompass a range of conditions characterized by excessive worry, fear, and apprehension. Image by Towfiqu Barbhuiya on Unsplash.

Marijuana 105

Marijuana Therapy Treatment Sleep 105

MMJ Recs

NOVEMBER 2, 2023

The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. In this article, we’ll explore MMJ patient success stories in West Virginia and how cannabis therapy is positively impacting patients’ lives.

Patients 98

Patients Chronic Pain Therapy Treatment 98

NORML

MARCH 7, 2020

The measure would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder as well as opioid use disorder. House Bill 158 authorizes the recommendation of medical marijuana in treating certain neurodegenerative diseases and conditions. Update : SB 2543 was approved by the Senate on 3/3/20.

Legislation 252

Legislation Decriminalization Patients THC 252

LifeCannMD

JANUARY 31, 2025

#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. “Every patient I see brings more than just their symptoms.”

Conditions 52

Conditions Research and Development Cannabinoids Sleep 52

Project CBD

FEBRUARY 27, 2023

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. They report that oral feeding of a single dose of cannabis oil was enough to mitigate some hallmarks of the condition in mice. Pain and therapy vol.

THC 144

THC CBD Clinical Trials Sleep 144

MMJ Recs

JULY 11, 2024

It can be caused by a variety of factors, including medical conditions, psychological issues, or environmental factors. It can be caused by underlying health conditions, medications, or psychological factors. Comorbid Insomnia : Also known as secondary insomnia, it occurs alongside another medical or psychiatric condition.

Sleep 111

Sleep Treatment Research and Development Therapy 111

MMJ Recs

JUNE 19, 2024

For medicinal marijuana laws across the United States, understanding the qualifying conditions for accessing medical cannabis is the first step. Understanding Qualifying Conditions for Medical Marijuana in Texas Texas defines qualifying conditions as medical ailments that warrant the use of medical marijuana for therapeutic purposes.

Conditions 52

Conditions Marijuana Treatment Patients 52

CannaMD

AUGUST 4, 2022

As medical marijuana continues to gain acceptance across the United States and beyond, patients are increasingly turning to cannabis-based therapies as a complement or alternative to prescription pharmaceutical drugs.

Patients 141

Patients Therapy Pharmaceutical Marijuana 141